Payment overview · 2025
General Payments
4 reported records · 2 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · NEW BRAUNFELS, TX · NPI 1598762205
Verified facts
CMS Open Payments records show Benjamin James Stevens, DO received $74.02 in general payments during 2025 across 4 reported records.
Amgen Inc. accounted for 75.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
4 reported records · 2 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $55.63 | 75.2% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $18.39 | 24.8% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $74.02 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $55.63 | 3 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $18.39 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 914 | 294 |
| Lisinopril | Lisinopril | 588 | 177 |
| Levothyroxine Sodium | Levothyroxine Sodium | 585 | 174 |
| Amlodipine Besylate | Amlodipine Besylate | 573 | 173 |
| Losartan Potassium | Losartan Potassium | 544 | 164 |
| Metformin Hcl | Metformin Hcl | 402 | 131 |
| Simvastatin | Simvastatin | 318 | 90 |
| Gabapentin | Gabapentin | 298 | 98 |
| Pantoprazole Sodium | Pantoprazole Sodium | 277 | 95 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 274 | 99 |
| Omeprazole | Omeprazole | 271 | 89 |
| Hydrochlorothiazide | Hydrochlorothiazide | 269 | 89 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 268 | 68 |
| Tramadol Hcl | Tramadol Hcl | 246 | 66 |
| Metoprolol Succinate | Metoprolol Succinate | 244 | 77 |
| Tamsulosin Hcl | Tamsulosin Hcl | 213 | 65 |
| Meloxicam | Meloxicam | 198 | 67 |
| Trazodone Hcl | Trazodone Hcl | 193 | 65 |
| Furosemide | Furosemide | 190 | 72 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 186 | 88 |
| Alendronate Sodium | Alendronate Sodium | 174 | 47 |
| Glipizide | Glipizide | 172 | 54 |
| Fluticasone Propionate | Fluticasone Propionate | 158 | 79 |
| Pravastatin Sodium | Pravastatin Sodium | 158 | 51 |
| Duloxetine Hcl | Duloxetine Hcl | 155 | 46 |
| Metoprolol Tartrate | Metoprolol Tartrate | 150 | 54 |
| Hydralazine Hcl | Hydralazine Hcl | 144 | 43 |
| Baclofen | Baclofen | 143 | 56 |
| Montelukast Sodium | Montelukast Sodium | 137 | 45 |
| Pregabalin | Pregabalin | 137 | 42 |
| Sertraline Hcl | Sertraline Hcl | 119 | 39 |
| Temazepam | Temazepam | 115 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 114 | 40 |
| Eliquis | Apixaban | 109 | 27 |
| Potassium Chloride | Potassium Chloride | 94 | 34 |
| Lorazepam | Lorazepam | 91 | 19 |
| Doxazosin Mesylate | Doxazosin Mesylate | 89 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 89 | 29 |
| Alprazolam | Alprazolam | 88 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 82 | 25 |
| Clonazepam | Clonazepam | 80 | 22 |
| Lovastatin | Lovastatin | 80 | 26 |
| Methylprednisolone | Methylprednisolone | 76 | 68 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 75 | 21 |
| Allopurinol | Allopurinol | 73 | 21 |
| Azithromycin | Azithromycin | 73 | 62 |
| Carvedilol | Carvedilol | 69 | 24 |
| Ozempic | Semaglutide | 67 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 66 | 19 |
| Ezetimibe | Ezetimibe | 63 | 25 |
| Prednisone | Prednisone | 59 | 35 |
| Myrbetriq | Mirabegron | 58 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 57 | 18 |
| Jardiance | Empagliflozin | 56 | 20 |
| Oxybutynin Chloride | Oxybutynin Chloride | 56 | 20 |
| Buspirone Hcl | Buspirone Hcl | 54 | 18 |
| Naproxen | Naproxen | 51 | 29 |
| Ropinirole Hcl | Ropinirole Hcl | 50 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 49 | 46 |
| Atenolol | Atenolol | 47 | 18 |
| Clonidine Hcl | Clonidine Hcl | 46 | 18 |
| Synthroid | Levothyroxine Sodium | 46 | 13 |
| Metformin Hcl Er | Metformin Hcl | 45 | 19 |
| Warfarin Sodium | Warfarin Sodium | 45 | 15 |
| Celecoxib | Celecoxib | 44 | 16 |
| Famotidine | Famotidine | 44 | 18 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 43 | 19 |
| Donepezil Hcl | Donepezil Hcl | 43 | 14 |
| Nifedipine Er | Nifedipine | 42 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 42 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 40 | 13 |
| Januvia | Sitagliptin Phosphate | 40 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 40 | 14 |
| Bupropion Xl | Bupropion Hcl | 39 | 14 |
| Ondansetron Odt | Ondansetron | 39 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 38 | 11 |
| Finasteride | Finasteride | 38 | 12 |
| Mirtazapine | Mirtazapine | 38 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 33 |
| Zolpidem Tartrate | Zolpidem Tartrate | 38 | suppressed |
| Spironolactone | Spironolactone | 37 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 37 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 35 | 14 |
| Glimepiride | Glimepiride | 34 | 11 |
| Topiramate | Topiramate | 34 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 34 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 31 | 21 |
| Paxlovid | Nirmatrelvir/Ritonavir | 31 | 31 |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 30 | 27 |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Estradiol | Estradiol | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 27 | 15 |
| Symbicort | Budesonide/Formoterol Fumarate | 27 | suppressed |
| Nystatin | Nystatin | 26 | 14 |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 25 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 24 | 13 |
| Meclizine Hcl | Meclizine Hcl | 24 | 17 |
| Memantine Hcl | Memantine Hcl | 24 | suppressed |
| Trulicity | Dulaglutide | 24 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 22 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Cephalexin | Cephalexin | 21 | 18 |
| Ibuprofen | Ibuprofen | 21 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 21 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 18 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Telmisartan | Telmisartan | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 13 | suppressed |
| Nabumetone | Nabumetone | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Jantoven | Warfarin Sodium | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $74.02 · 4 records | Amgen Inc. | Cologuard Collection Kit, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error